Tokyo, Aug. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062637) titled 'Questionnaire study on wearing-off in patients with Parkinson's disease' on Aug. 24.
Study Type:
Observational
Primary Sponsor:
Institute - ONO PHARMACEUTICAL CO., LTD.
Condition:
Condition - Parkinson's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to conduct a questionnaire survey among patients with Parkinson's disease and to clarify the actual timing of symptom occurrence associated with wearing-off in Parkinson's disease.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=18 years at the time of consent.
3. Patients who self-report a confirmed diagnosis of Parkinson's disease.
4. Patients who take oral levodopa formulations at least three times per day.
Key exclusion criteria - 1.Patients who self-report a physician diagnosis of dementia.
Target Size - 560
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 10 Day
Date of IRB - 2026 Year 07 Month 28 Day
Anticipated trial start date - 2026 Year 09 Month 01 Day
Last follow-up date - 2026 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071696
Disclaimer: Curated by HT Syndication.
